Navigation Links
CryoLife to Distribute FDA-approved Hemostatic Agent Under Private Label
Date:4/17/2008

ATLANTA, April 17 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE: CRY), a biomaterials, medical device and tissue processing company, announced today that it has signed an exclusive three-year agreement with Minneapolis-based Medafor, Inc. Under terms of the agreement CryoLife will distribute Medafor's microporous polysaccharide hemostatic agent for use in cardiac and vascular surgery in the U.S. and for cardiac, vascular and general surgery, other than orthopaedic and ear, nose and throat surgery, outside the U.S. (excluding Japan and China).

CryoLife expects to begin distributing Hemostase MPH in the U.S. in the second quarter of 2008, except to approximately 41 hospitals for which Medafor will retain distribution rights until no later than December 31, 2008. Outside of the U.S., CryoLife expects to begin distributing Hemostase MPH in Canada, United Kingdom and Germany in the second quarter of 2008, with distribution in other markets beginning in 2009. Department of Defense hospitals are excluded from CryoLife's territory under the distribution agreement, but Veterans' Administration Hospitals are included.

The unique, absorbable powder hemostat, which received CE Mark approval in 2003 and FDA pre-market approval in September 2006, will be distributed by CryoLife under the private label name Hemostase MPH.

Hemostase MPH is developed using Medafor's exclusive, licensed Microporous Polysaccharide Hemospheres technology (MPH(R)), which yields a plant-based, flowable powder engineered to rapidly dehydrate blood, enhancing clotting on contact. When used as directed, this highly effective hemostatic agent facilitates the formation of a resilient, natural clot within just a few minutes.

Available in a convenient read
'/>"/>

SOURCE CryoLife, Inc.
Copyright©2008 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. CryoLife Closes on $15 Million Credit Facility with GE Healthcare Financial Services
2. CryoLife Announces Implant of First FDA-Cleared SynerGraft(R) Processed Human Pulmonary Heart Valve
3. CryoLife to Present at Roth Capital Partners 20th Annual Orange County (OC) Growth Stock Conference
4. CryoLife Receives FDA 510(k) Clearance for SynerGraft(R) Processed Human Pulmonary Heart Valves
5. CryoLife Announces Release Date and Teleconference Call Details for the Fourth Quarter and Year End 2007 Financial Results
6. Cryolife Once Again Severely Maims an Innocent Knee Surgery Patient
7. CryoLife Responds to Inaccurate Assertions from Plaintiffs Attorney
8. CryoLife Announces Record Preservation Services and Product Revenues for 2007
9. CryoLife to Present at OneMedPlace Finance Forum
10. CryoLife to Present at 19th Annual Piper Jaffray Health Care Conference in New York
11. CryoLife to Conduct Annual Cardiac Surgery Fellows Allograft Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2009)... EntreMed, Inc. (Nasdaq: ENMD ), ... royalty revenue from sales of Thalomid® during the ... $3.3 million. In addition, the Company anticipates ... for fiscal 2009. The difference in estimated ... be reflected in the fourth quarter financial results. ...
(Date:12/11/2009)... December 10, 2009 miRagen Therapeutics, Inc., a ... developing innovative microRNA-based therapeutics for cardiovascular and muscle ... that microRNA-206 (miR-206) plays a crucial role in ... Lou Gehrig,s disease) and in neuromuscular synaptic regeneration ... December 11 issue of the journal Science ...
(Date:12/11/2009)... HILL, MA (12/11/2009) Boston College researchers have observed ... the first time and successfully harvested the elusive charges ... improved solar power efficiency, the authors report in the ... , When light is captured in solar cells, it ... But in order to snare these charges, the electrons ...
(Date:12/11/2009)... Algeta ASA (OSE: ALGETA), the,cancer ... center in the,US, the Tulane Cancer Center, ... phase III clinical study of Alpharadin in ... cancer,(CRPC) that has metastasized to the skeleton. ... (ALpharadin in SYMptomatic Prostate CAncer) study is ...
Breaking Biology Technology:EntreMed Reports Receipt of Third Quarter Royalty Payment 2miRagen announces discovery of key microRNA implicated in Lou Gehrig's disease 2Elusive 'hot' electrons captured in ultra-thin solar cells 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 4
... American Academy of Pediatrics National Conference & ... ... Pa., Oct. 29 Tengion,Inc., a leader in regenerative medicine, announced ... American Academy of,Pediatrics (AAP) National Conference and Exhibition demonstrate the ability,of ...
... SAN MARCOS, Calif., Oct. 29 Cliniqa ... diagnostic products, is pleased to,announce the acquisition ... "Raichem" (San Diego, CA), a wholly owned ... is a manufacturer of clinical,diagnostic products focusing ...
... Repair Discussed at American Society of Plastic Surgeons ... ... the debut of NBC,s,"Bionic Woman," the notion of a bionic person ... getting closer to reality,as reconstructive plastic surgeons perform quality-of-life-enhancing,peripheral nerve surgeries ...
Other Biology Technology:Preclinical Efficacy Data Demonstrate Ability of Tengion's Neo-Bladder Augment to Restore Bladder Function 2Preclinical Efficacy Data Demonstrate Ability of Tengion's Neo-Bladder Augment to Restore Bladder Function 3Cliniqa Corporation Completes Asset Acquisition of Reagents Applications, Inc. 2Creating the Bionic Woman: Making Nerves Spring Back to Life 2Creating the Bionic Woman: Making Nerves Spring Back to Life 3
(Date:12/11/2009)... professor of anthropology at the University of Arizona, has ... understand how violence shapes the health of those eking ... and her colleagues, research," Documenting the health consequences of ... A conceptual framework," is currently published in a special ... collaboration with the British medical journal the Lancet ...
(Date:12/11/2009)... edition of Springer,s classic reference and textbook Vogel and ... McKusick Leadership Award. The prize, which recognizes Professor Motulsky,s ... presented to him at the 59th Annual Meeting of ... 2009 in Honolulu, Hawaii. , Motulsky is Professor Emeritus ... Washington in Seattle. One of the founding giants of ...
(Date:12/11/2009)... lost a moderate amount of weight by eating less ... study at Washington University School of Medicine in St. ... in the Dec. 15, 2009, issue of the ... that weight loss led to improvement in four key ... in the study participants included decreased thickness of heart ...
Breaking Biology News(10 mins):UA-led study grapples with health effects of low-intensity warfare 2Moderate weight loss in obese people improves heart function 2Moderate weight loss in obese people improves heart function 3From the glass to the brain in 6 minutes 8835 1From the glass to the brain in 6 minutes 8835 2Hard to Treat Diseases Inc 28HTDS 29 Finalizes Agreement with Yunnan Walvax Biotech 48920 1Hard to Treat Diseases Inc 28HTDS 29 Finalizes Agreement with Yunnan Walvax Biotech 48920 2Finding Raises Hope for Treating ALS 48916 1Finding Raises Hope for Treating ALS 48916 2
... the Biomedical Engineering Society (BMES) will launch a ... (CMBE) in March 2008. Springer is already ... Biomedical Engineering. , Cellular and Molecular Bioengineering ... of cellular and molecular bioengineering, thus advancing this ...
... A consortium of researchers led by the Genome Sequencing Center ... the completion of a draft sequence of the corn genome. ... partnership with the U.S. Department of Agriculture (USDA) and the ... to sequence the corn genome. The goal of the project ...
... Dr. Peter Glynn, a professor at the University of ... been selected to receive the 2007-2008 Provosts Award for ... pursuits, and provides the recipient with a cash award ... time Glynn, who received the award when it was ...
Other Biology News:Springer expands publishing partnership with the Biomedical Engineering Society 2All eyes and ears on the corn genome 2All eyes and ears on the corn genome 3UM coral scientist Peter Glynn wins award for scholarly activity 2
... the caudal-related homeobox family, is an intestine-specific ... differentiation in intestinal epithelial cells. It plays ... the phenotype of differentiated villus enterocytes as ... phenotype. Clone CDX2-88 reacts with a conserved ...
Rabbit polyclonal to VPAC2 ( Abpromise for all tested applications). entrezGeneID: 7434 SwissProtID: P41587...
Mouse Anti-Human Methyl-CpG binding domain protein 2 (MBD2 Monoclonal Antibody Family: Other Applications: Western Blot...
... and rocking for maximal fluid movement. This unit ... steel or acrylic platform, it is perfect for ... platform angle is easily adjusted from 0 to ... rotation speed of platform is adjusted from 0 ...
Biology Products: